Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

• G Van Assche

• W J Sandborn

• B G Feagan

• B A Salzberg

• D Silvers

• P S Monroe

• W M Pandak

• F H Anderson

• J F Valentine

• G E Wild

• D J Geenen

• R Sprague

• S R Targan

• P Rutgeerts

• V Vexler

• D Young

• R S Shames

収録刊行物

• Gut

  Gut 55 (11), 1568-1574, 2006-11-01

  BMJ

キーワード

• Gastroenterology

詳細情報

• CRID: 1361137045071725184
• NII論文ID: 30021595024
• DOI: 10.1136/gut.2005.089854
• ISSN: 00175749
• Web Site: https://syndication.highwire.org/content/doi/10.1136/gut.2005.089854
• データソース種別:
  • Crossref
  • CiNii Articles